 |
| MJNA Sponsors Major Event MLCG Closes Up Yesterday |
|
 Hot Stock to Watch
|
Company: Medical Marijuana Inc. (Pink Sheets: MJNA)
|
End of Day:
Price: 0.205
Change (%): - 0.014 (6.39)
Volume: 10,024,703 |
 |
Medical Marijuana Inc.’s HempMeds Title Sponsor of National Cannabis Industry Association Denver Conference
SAN DIEGO, April 15, 2014 (GLOBE NEWSWIRE) - Medical Marijuana Inc. (OTC Pink:MJNA) is pleased to announce that its subsidiary company, HempMeds™, is the sponsor of the National Cannabis Industry Association (NCIA)’s NCIA “Educational Series” conference in Denver. The conference takes place on Tuesday, April 15th at the Exdo Events Center at 1399 35th St. Denver, Colorado 80205. The NCIA focuses on three key elements: protecting legitimate cannabis businesses, banking access for those businesses, and fair tax policy. The organization’s mission is to lead a unified and coordinated effort to ensure the cannabis industry is treated fairly under federal law. The conference agenda includes an invitation-only reception, business networking, and panel discussion.
“We applaud the efforts of the NCIA and their mission to ensure that responsible and legitimate cannabis-related businesses are treated fairly,” states Charles Vest, VP of Communications for HempMeds™. “As the title sponsor of the NCIA’s Educational Series conference during the historic ’420 week,’ HempMeds™ is showing support for all cannabis businesses in this rapidly growing and changing industry.”
Continue Reading
|
 Yesterday's Top Performer
|
Company: ML Capital Group, Inc. (OTCQB: MLCG)
|
End of Day:
Price: 0.085
Change (%): + 0.005 (6.25)
Volume: 155,237 |
 |
About ML Capital Group, Inc.:
ML Capital Group, Inc.'s primary business consists of providing management, financial and strategic consulting services designed to advance and improve an organization's ability to conduct its business more effectively and to foster sales growth, with a principal focus on assisting companies in the green technology industry as well as produces, markets and sells its own branded products that are specifically focused on the medical marijuana, or "green medicine," industry.
Company Information Sheet |
Other Small Cap News
|
Company: Nuvilex, Inc. (OTCQB: NVLX)
|
Nuvilex Contracts With Clinical Network Services Pty Ltd for Late-Phase Clinical Trials in Pancreatic Cancer
SILVER SPRING, Md., April 15, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that it has contracted Clinical Network Services Pty Ltd (CNS), a fully integrated drug development company based in Australia, New Zealand and the United Kingdom, to handle every aspect of Nuvilex's late-phase clinical trials in pancreatic cancer as Nuvilex's Contract Research Organization (CRO). The trials, which will focus on treatment for advanced stage pancreatic cancer, will involve Nuvilex's pancreatic cancer treatment (a combination of the proprietary "Cell in-a-Box®" live-cell encapsulation technology and the cancer drug ifosfamide) which has already proved effective in early stage trials.
Continue Reading
|
Company: Cannabis Therapy Corp. (OTCQB: CTCO)
|
Cannabis Therapy Corp. Appoints Science Pioneer Dr. Cohava Gelber to Board
Company Appointment Demonstrates Commitment to Scientific Excellence
NEW YORK, NY--(Marketwired - Apr 15, 2014) - Cannabis Therapy Corp. (OTCQB: CTCO) (the "Company") a development stage enterprise focused on the business of manufacturing and marketing pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of cannabis, for the treatment of various conditions and diseases, is very pleased to confirm the expert services of Dr. Cohava Gelber through her appointment to its growing Board of Directors.
Continue Reading |
Market News
|
By Matthew J. Belvedere: CNBC
|
This could return greed to Wall Street: Paulsen
Signals from the bond market highlight concerns about the economy's strength, but James Paulsen-chief investment strategist at Wells Capital Management-told CNBC on Tuesday that growth is better than many investors think.
"I think we're north of 3 percent [economic growth]. I think the reports have been pretty darn good," he said in a "Squawk Box" interview. "If you look at the data on Main Street, I think it's definitely notched up."
During last week's sharp selloff in stocks-which saw bond prices rise-Paulsen argued that encouraging reports on jobless claims and consumer confidence may have been lost in the shuffle.
Continue Reading
|
By Daryl Guppy: CNBC
|
As the Nasdaq falls a buying opportunity arises
The Nasdaq pullback that we forecasted in January has commenced. Following its stellar 38.3 percent rise in 2013 the Nasdaq has lost momentum as the Federal Reserve further tapers its asset-purchase program. Down 3.4 percent year to date, the index suffered its biggest single-day drop in two-and-a-half years last Thursday underscoring the pullback.
This raises one key question for investors: is this is a temporary retreat, or a significant change in the trend? A retreat would present a buying opportunity for a continuation of the uptrend, while a change in the direction of the trend would be a sell signal to protect profits.
The Nasdaq has a steady and strong up-sloping trading channel which is best seen on a monthly chart. The chart has three analysis features: a trading channel; potential upside targets; the position of long-term uptrend line A.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
